Mephentermine

Mephentermine
Clinical data
Other names	methyl(2-methyl-1-phenylpropan-2-yl)amine
Routes of; administration	IM/IV
ATC code	C01CA11 (WHO) ;
Legal status
Legal status	US: Schedule I (positional isomer of Etilamfetamine);
Pharmacokinetic data
Metabolism	Rapidly demethylated in the body followed by hydroxylation.
Excretion	Via urine (as unchanged and metabolites); more rapid in acidic urine.
Identifiers
	IUPAC name N,2-dimethyl-1-phenylpropan-2-amine;
CAS Number	100-92-5 ;
PubChem CID	3677;
IUPHAR/BPS	7222;
DrugBank	DB01365 ;
ChemSpider	3549 ;
UNII	TEZ91L71V4;
KEGG	D08180 ;
ChEMBL	ChEMBL1201234 ;
CompTox Dashboard (EPA)	DTXSID4023256 ;
ECHA InfoCard	100.002.638
Chemical and physical data
Formula	C11H17N
Molar mass	163.264 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES N(C(Cc1ccccc1)(C)C)C;
	InChI InChI=1S/C11H17N/c1-11(2,12-3)9-10-7-5-4-6-8-10/h4-8,12H,9H2,1-3H3 ; Key:RXQCGGRTAILOIN-UHFFFAOYSA-N ;
	(what is this?) (verify)

Mephentermine (Wyamine, former brandname) is a cardiac stimulant.

It has been used as a treatment for low blood pressure.

Mephentermine belongs to the class of adrenergic and dopaminergic cardiac stimulants excluding cardiac glycosides. Used in the treatment of heart failure.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.